
A study assessed the effect of baseline glycated hemoglobin (HbA1c) levels on atrial fibrillation (AF) recurrence following cryoballoon ablation in patients with and without diabetes. Consecutive AF patients receiving first cryoballoon ablation between April 2018 and April 2021 were included. The primary outcome was AF recurrence after ablation at the longest follow-up. Multivariate Cox proportional hazards regression models were utilized to calculate the hazard ratio (HR) and 95% CI per standard deviation (SD) increase of baseline HbA1c level. Baseline HbA1c level was an independent predictor of AF recurrence following cryoablation, both in patients with and without diabetes.
Like
Save
Share